Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Reset all filters
01 1Biophore India Pharmaceuticals Pvt Ltd
02 1Aptra Synthesis
03 1HRV Global Life Sciences
04 1Porton Pharma Solutions
05 1Aurobindo Pharma Limited
06 1CHEMO
07 1Gedeon Richter
08 1Hetero Drugs
09 1Kimia Biosciences
10 1Lee Pharma
11 1MSN Laboratories
12 1Maprimed
13 1Morepen Laboratories
14 1Nifty Labs
15 2Sionc Pharmaceuticals
16 1Sun Pharmaceutical Industries Limited
17 1Synaptics Labs
18 1Tivan Sciences
19 1UQUIFA
20 1Zhejiang Huahai Pharmaceutical
21 1Blank
Reset all filters
01 1Argentina
02 2China
03 1Hungary
04 15India
05 2Spain
06 1Blank
Reset all filters
01 9Active
02 13Blank
01 22Blank
Reset all filters
01 22Blank
Reset all filters
01 1WC-0168
02 1WC-0186
03 1WC-0273
04 1WC-0273A7
05 18Blank
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33846
Submission : 2019-05-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33399
Submission : 2018-12-14
Status : Active
Type : II
NDC Package Code : 14501-0035
Start Marketing Date : 2018-12-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38749
Submission : 2023-09-14
Status : Active
Type : II
Date of Issue : 2023-03-21
Valid Till : 2025-07-28
Written Confirmation Number : WC-0186
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-07-31
Pay. Date : 2019-07-18
DMF Number : 33834
Submission : 2019-07-18
Status : Active
Type : II
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-07-23
Pay. Date : 2019-06-26
DMF Number : 33956
Submission : 2019-06-26
Status : Active
Type : II
NDC Package Code : 59651-400
Start Marketing Date : 2024-01-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/50kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26321
Submission : 2012-07-26
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-08-14
Pay. Date : 2019-03-15
DMF Number : 33623
Submission : 2019-03-22
Status : Active
Type : II
NDC Package Code : 57741-3700
Start Marketing Date : 2015-07-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-11-14
Pay. Date : 2023-09-27
DMF Number : 38933
Submission : 2023-09-26
Status : Active
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40029
Submission : 2024-06-28
Status : Active
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Date of Issue : 2020-03-18
Valid Till : 2020-05-11
Written Confirmation Number : WC-0273A7
Address of the Firm :
NDC Package Code : 76055-0042
Start Marketing Date : 2019-07-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2020-07-23
Valid Till : 2023-05-11
Written Confirmation Number : WC-0273
Address of the Firm :
NDC Package Code : 76055-0042
Start Marketing Date : 2019-07-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
60
PharmaCompass offers a list of Cariprazine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cariprazine Hydrochloride manufacturer or Cariprazine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cariprazine Hydrochloride manufacturer or Cariprazine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Cariprazine Hydrochloride API Price utilized in the formulation of products. Cariprazine Hydrochloride API Price is not always fixed or binding as the Cariprazine Hydrochloride Price is obtained through a variety of data sources. The Cariprazine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A VRAYLAR manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of VRAYLAR, including repackagers and relabelers. The FDA regulates VRAYLAR manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. VRAYLAR API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of VRAYLAR manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A VRAYLAR supplier is an individual or a company that provides VRAYLAR active pharmaceutical ingredient (API) or VRAYLAR finished formulations upon request. The VRAYLAR suppliers may include VRAYLAR API manufacturers, exporters, distributors and traders.
click here to find a list of VRAYLAR suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 20 companies offering VRAYLAR
Get in contact with the supplier of your choice: